Invion Limited
Invion Limited, a clinical-stage life sciences company, researches and develops Photosoft technology for the treatment of cancers, atherosclerosis, and infectious diseases in Australia. The company develops IVX-PDT, a photosensitising agent to treat a range of cancers, such as skin, prostate, ano-genital, glioblastoma multiforme, lung, and ovarian cancers; and human papilloma virus. It is also in… Read more
Invion Limited (IVIXF) - Total Assets
Latest total assets as of December 2025: $5.40 Million USD
Based on the latest financial reports, Invion Limited (IVIXF) holds total assets worth $5.40 Million USD as of December 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Invion Limited - Total Assets Trend (2014–2025)
This chart illustrates how Invion Limited’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Invion Limited - Asset Composition Analysis
Current Asset Composition (June 2025)
Invion Limited's total assets of $5.40 Million consist of 9.8% current assets and 90.2% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 9.0% |
| Accounts Receivable | $0.00 | 0.0% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $5.62 Million | 90.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2014–2025)
This chart illustrates how Invion Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Invion Limited's current assets represent 9.8% of total assets in 2025, a decrease from 32.3% in 2014.
- Cash Position: Cash and equivalents constituted 9.0% of total assets in 2025, down from 26.8% in 2014.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 89.0% of total assets, an increase from 67.0% in 2014.
- Asset Diversification: The largest asset category is intangible assets at 90.0% of total assets.
Invion Limited Competitors by Total Assets
Key competitors of Invion Limited based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF
|
USA | $67.26 Billion |
|
Kamada
NASDAQ:KMDA
|
USA | $378.79 Million |
|
One World Pharma Inc
OTCQB:OWPC
|
USA | $6.62 Million |
|
Dongwha Pharm.Co.Ltd
KO:000020
|
Korea | ₩654.63 Billion |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
|
China | CN¥27.28 Billion |
|
Yuhan Corp.
KO:000100
|
Korea | ₩3.05 Trillion |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
|
China | CN¥4.97 Billion |
|
Kotra Industries Bhd
KLSE:0002
|
Malaysia | RM363.90 Million |
Invion Limited - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Invion Limited generates 0.16x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Invion Limited is currently not profitable relative to its asset base.
Invion Limited - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.14 | 1.24 | 3.04 |
| Quick Ratio | 0.14 | 1.24 | 3.04 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-1.37 Million | $ 106.34K | $ 441.35K |
Invion Limited - Advanced Valuation Insights
This section examines the relationship between Invion Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.82 |
| Latest Market Cap to Assets Ratio | 0.33 |
| Asset Growth Rate (YoY) | -59.6% |
| Total Assets | $6.25 Million |
| Market Capitalization | $2.07 Million USD |
Valuation Analysis
Below Book Valuation: The market values Invion Limited's assets below their book value (0.33 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Invion Limited's assets decreased by 59.6% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Invion Limited (2014–2025)
The table below shows the annual total assets of Invion Limited from 2014 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-06-30 | $6.25 Million | -59.58% |
| 2024-06-30 | $15.45 Million | +21.81% |
| 2023-06-30 | $12.69 Million | -8.27% |
| 2022-06-30 | $13.83 Million | +226.47% |
| 2021-06-30 | $4.24 Million | +6.80% |
| 2020-06-30 | $3.97 Million | -6.76% |
| 2019-06-30 | $4.25 Million | -44.37% |
| 2018-06-30 | $7.65 Million | +71.52% |
| 2017-06-30 | $4.46 Million | -50.03% |
| 2016-06-30 | $8.92 Million | -44.58% |
| 2015-06-30 | $16.10 Million | +9.29% |
| 2014-06-30 | $14.73 Million | -- |